Article Versions Notes

Liao Z, Chen X, Brusini R, Faivre J, Applegate LA, Flegeau K, Hirt-Burri N. Non-Crosslinked Hyaluronic Acid Redensity 1^® Supports Cell Viability, Proliferation, and Collagen Deposition in Early Burn Management. Pharmaceutics. 2026; 18(1):21. https://doi.org/10.3390/pharmaceutics18010021

Liao, Zhifeng, Xi Chen, Romain Brusini, Jimmy Faivre, Lee Ann Applegate, Killian Flegeau, and Nathalie Hirt-Burri. 2026. "Non-Crosslinked Hyaluronic Acid Redensity 1^® Supports Cell Viability, Proliferation, and Collagen Deposition in Early Burn Management" Pharmaceutics 18, no. 1: 21. https://doi.org/10.3390/pharmaceutics18010021

Liao, Z., Chen, X., Brusini, R., Faivre, J., Applegate, L. A., Flegeau, K., & Hirt-Burri, N. (2026). Non-Crosslinked Hyaluronic Acid Redensity 1^® Supports Cell Viability, Proliferation, and Collagen Deposition in Early Burn Management. Pharmaceutics, 18(1), 21. https://doi.org/10.3390/pharmaceutics18010021